Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

19
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
19
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

18
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
18
Liver Histology01:27

Liver Histology

2.1K
The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
2.1K
Liver Physiology01:30

Liver Physiology

1.9K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.9K
Liver Regeneration01:24

Liver Regeneration

3.5K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scientific Opinion of Flavouring Group Evaluation 407 (FGE.407): 4-amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acid.

EFSA journal. European Food Safety Authority·2020
Same author

Safety assessment of the substance 'Tungsten Oxide' for use in food contact materials.

EFSA journal. European Food Safety Authority·2020
Same author

Scientific Opinion on Flavouring Group Evaluation 63, Revision 3 (FGE.63Rev3): aliphatic secondary alcohols, ketones and related esters evaluated by JECFA (59th and 69th meetings) structurally related to saturated and unsaturated aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated linear or branched-chain carboxylic acids evaluated by EFSA in FGE.07Rev4.

EFSA journal. European Food Safety Authority·2020
Same author

Safety evaluation of the food enzyme pullulanase from <i>Pullulanibacillus naganoensis</i> strain AE-PL.

EFSA journal. European Food Safety Authority·2020
Same author

Safety evaluation of the food enzyme peroxidase obtained from soybean (<i>Glycine max</i>) hulls.

EFSA journal. European Food Safety Authority·2020
Same author

Safety assessment of the mixture of methyl-branched and linear C<sub>14</sub>-C<sub>18</sub> alkanamides, derived from fatty acids, for use in food contact materials.

EFSA journal. European Food Safety Authority·2020

Related Experiment Video

Updated: Oct 11, 2025

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

9.3K

Liver Disease: Cirrhosis.

Katrina Baumgartner1, Julia Cooper2, Andrew Smith1

  • 1Department of Family Medicine - Tufts University School of Medicine, 136 Harrison Ave, Boston, MA 02111.

FP Essentials
|December 2, 2021
PubMed
Summary

Cirrhosis, characterized by liver scarring, impairs function but may be reversible. Early diagnosis and management of underlying causes and complications are crucial for patient outcomes.

More Related Videos

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.0K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

53.1K

Related Experiment Videos

Last Updated: Oct 11, 2025

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

9.3K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.0K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

53.1K

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Cirrhosis involves pathological liver scarring, leading to impaired function and significant disease burden.
  • It arises from chronic liver inflammation (e.g., NAFLD, viral hepatitis, alcohol use) and can progress from compensated to decompensated stages.
  • Decompensation manifests as ascites, hepatic encephalopathy, or variceal bleeding.

Purpose of the Study:

  • To outline the diagnosis, management, and complications of cirrhosis.
  • To emphasize the role of both noninvasive testing and liver biopsy in diagnosis.
  • To guide clinical assessment, patient counseling, and indications for liver transplantation.

Main Methods:

  • Diagnosis relies on history, physical examination, noninvasive tests (labs, scoring indices, imaging), and liver biopsy when indicated.
  • Management includes addressing the underlying cause, avoiding hepatotoxic drugs, and regular clinical assessment (every 6 months).
  • Monitoring involves laboratory tests and calculating Child-Pugh and Model for End-stage Liver Disease (MELD) scores.

Main Results:

  • Noninvasive evaluations are primary diagnostic tools, with liver biopsy reserved for indeterminate cases or unknown etiology.
  • Regular clinical assessment and scoring (Child-Pugh, MELD) are essential for monitoring disease progression.
  • Management strategies focus on underlying causes, lifestyle modifications, and preventing/treating complications.

Conclusions:

  • Cirrhosis diagnosis integrates noninvasive methods and biopsy when necessary.
  • Proactive management of underlying causes, complications, and lifestyle factors is key.
  • Liver transplantation evaluation is indicated for MELD score ≥15, complications, or hepatocellular carcinoma.